Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Oct 17;10:CD010005. doi: 10.1002/14651858.CD010005.pub2

Figure 6. Cates plot of monotherapy versus placebo trials.

Figure 6

In the placebo group 36 people out of 1000 had non-fatal serious adverse events of any cause over 29 weeks, compared to 57 (95% CI 40 to 81) out of 1000 for the LABA monotherapy group. The crossed-out faces show that there were 21 additional children suffering an SAE for every 1000 treated with LABA monotherapy.

HHS Vulnerability Disclosure